Trending Now
Business
Charles Barkley – Quit Worrying About Those ‘Stupid Statues’
The riots that marred an alt-right rally last weekend in Charlottesville have dominated the 24-hour news cycle. The rally was in reaction to the...
XXXTentacion Accused Killer Assaulted In Jail; That Was Quick
Last month rapper XXXTentacion was murdered in Florida while leaving a bike shop. The details of the murder are still murky. Initial reports suggested...
Lifestyle today
Entertainment
Allergan: Is Revance The Botox Killer?
Allergan (AGN) bulls recently received some bad news. Revance Therapeutics (RVNC) reported two SAKURA Phase 3 trials for its next-generation neuromodulator DaxibotulinumtoxinA for Injection...
Endo: Women Discuss Commercial Appeal For Xiaflex To Treat Cellulite
On February 11th experts discussed Endo International, Xiaflex and Cellulite. The discussion was led by Senator Maria Chappelle-Nadal, Ralph Baker of Shocking The Street...
Allergan, Mohawks Receive IPR Stay For Restasis
Wednesday market chatter suggested a Federal Circuit Court stayed an inter partes review ("IPR") pursuant to patents for Allergan's (AGN) dry eye drug Restasis....
Mallinckrodt: The $4 Billion Pink Elephant In The Room
Mallinckrodt's (MNK) top product, Acthar, began to crack in Q3 2017. Revenue from Acthar fell 6% Y/Y, while the company's total revenue was off...
Talk To Ebro On Rap; Attend Trump And The GE On Trump
President Trump is arguably the most-polarizing figure ever in the White House; he seems to revel in that distinction. He call NFL players "sons...
Trump And The GE Parses Kolodny’s Opioid Hoax December 2nd At 7PM
The opioid epidemic has dominated the 24-hour news cycle for the past four years. Drug overdose deaths have surpassed car accidents pursuant...
Biden Needs To End Fake Opioid Lawsuits
The opioid epidemic has dominated the 24-hour news cycle for the past four years. Drug overdose deaths have surpassed car accidents pursuant...
Endo Q1 Earnings Preview
Endo International (ENDP) reports quarterly earnings May 9th. Analysts expect revenue of $691.82 million and eps of $0.43. The revenue estimate implies a 1%...
























































































































